FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse

被引:4
|
作者
Gill, Harinder [1 ]
Ip, Ho-Wan [2 ]
Pang, Annie W. K. [1 ]
Sum, Joey [1 ]
Leung, Anskar Y. H. [1 ]
Kwong, Yok-Lam [1 ]
机构
[1] Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
Acute Myeloid Leukemia; Hematopoietic Stem Cell Transplantation; Acute Promyelocytic Leukemia; As2O3; Idarubicin;
D O I
10.1007/s00277-014-2281-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1049 / 1051
页数:3
相关论文
共 50 条
  • [31] Evolution of FLT3 internal tandem duplication at the diagnosis, relapse, remission or induction failure during the treatment in acute myeloblastic leukemia.
    Bang, Soo-Mee
    Ahn, Jeong Yeal
    Park, Jiyoon
    Park, Se Hoon
    Nam, Eon Mi
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae-Hoon
    Yoo, Soo Jin
    Jeon, In Sang
    Kim, Yeo-Kyeoung
    Kim, Hyeoung Joon
    Kim, Hee-Nam
    Lee, Il-Kwon
    Kang, Hyoung Jin
    Shin, Hee Young
    Ahn, Hyo Seop
    BLOOD, 2006, 108 (11) : 200B - 200B
  • [32] CABOZANTINIB IS SELECTIVELY CYTOTOXIC IN ACUTE MYELOID LEUKEMIA CELLS WITH INTERNAL TANDEM DUPLICATION OF FLT3 (FLT3-ITD)
    Wang, A.
    Lu, J. W.
    Hou, H. A.
    Chen, C. Y.
    Hu, C. Y.
    Ou, D. L.
    Ko, Y. C.
    Tien, H. F.
    Lin, L. I.
    HAEMATOLOGICA, 2014, 99 : 291 - 291
  • [33] The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients
    V Ponziani
    G Gianfaldoni
    F Mannelli
    F Leoni
    S Ciolli
    P Guglielmelli
    E Antonioli
    G Longo
    A Bosi
    A M Vannucchi
    Leukemia, 2006, 20 : 2074 - 2076
  • [34] The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients
    Ponziani, V.
    Gianfaldoni, G.
    Mannelli, F.
    Leoni, F.
    Ciolli, S.
    Guglielmelli, P.
    Antonioli, E.
    Longo, G.
    Bosi, A.
    Vannucchi, A. M.
    LEUKEMIA, 2006, 20 (11) : 2074 - 2076
  • [35] Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
    Dillon, Laura W.
    Gui, Gege
    Ravindra, Niveditha
    Andrew, Georgia
    Mukherjee, Devdeep
    Wong, Zoe C.
    Huang, Ying
    Gerhold, Jason
    Holman, Matt
    D'Angelo, Julian
    Miller, Jeffrey
    Higgins, Jake
    Salk, Jesse J.
    Auletta, Jeffery J.
    El Chaer, Firas
    Devine, Steven M.
    Jimenez-Jimenez, Antonio Martin
    De Lima, Marcos J. G.
    Litzow, Mark R.
    Kebriaei, Partow
    Saber, Wael
    Spellman, Stephen R.
    Zeger, Scott L.
    Page, Kristin M.
    Hourigan, Christopher S.
    JAMA ONCOLOGY, 2024, 10 (08) : 1104 - 1110
  • [36] Prognostic significance of FLT3 internal tandem duplication in Egyptian acute myeloid leukemia and normal cytogenetics
    Rabab Aly
    Dina Shahin
    Emad Azmy
    Comparative Clinical Pathology, 2012, 21 (5) : 1029 - 1035
  • [37] Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia
    Stirewalt, DL
    Kopecky, KJ
    Meshinchi, S
    Engel, JH
    Pogosova-Agadjanyan, EL
    Linsley, J
    Slovak, ML
    Willman, CL
    Radich, JP
    BLOOD, 2006, 107 (09) : 3724 - 3726
  • [38] Double induction in acute myeloid leukemia (AML) with Flt3 gene internal tandem duplication.
    Boissel, N
    Cayuela, JM
    Fund, X
    Raffoux, E
    Taksin, AL
    Rousselot, P
    Sigaux, F
    Degos, L
    Castaigne, S
    Dombret, H
    BLOOD, 2000, 96 (11) : 316A - 317A
  • [39] Detection of FLT3 internal tandem duplication mutations in Chinese acute myeloid leukemia patients.
    Wang, LH
    Zhou, CL
    Chen, S
    Wang, M
    Wang, JX
    BLOOD, 2003, 102 (11) : 219B - 219B
  • [40] A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations
    Levis, M
    Tse, KF
    Smith, BD
    Garrett, E
    Small, D
    BLOOD, 2001, 98 (03) : 885 - 887